You are here:

The impact of COVID-19 on TB: a review of the data

Published on


To ensure that scientific research of immediate concern is shared as rapidly as possible, we fast-track accepted articles from the IJTLD and PHA and publish them as edited preprints prior to publication in a journal.

Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at for details.  Find out more about the IJTLD.

Read the PDF for more information, including the Figures, Tables and References

C. F. McQuaid, A. Vassall, T. Cohen, K. Fiekert, COVID/TB Modelling Working Group, R. G. White

Article submitted 9 March 2021. Final version accepted 23 March 2021.

Early in the COVID-19 pandemic, models predicted hundreds of thousands of additional TB deaths as a result of health service disruption. To date, empirical evidence on the effects of COVID-19 on TB outcomes has been limited. In this Review, the authors summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts. From the data, it is clear that there have been substantial disruption to TB health services and an increase in vulnerability to TB. Evidence for changes in Mycobacterium tuberculosis transmission is limited, and it remains unclear how the resources required and available for the TB response have changed. To advocate for additional funding to mitigate the impact of COVID-19 on the global TB burden, and to efficiently allocate resources for the TB response, requires a significant improvement in the TB data available.

Read the PDF for more information, including the Figures, Tables and References